Evoke Pharma, Inc. (EVOK)

Trade EVOK now with
6/4/2018 7:34:43 AM Evoke Announces FDA Submission Of NDA For Gimoti
5/14/2018 6:32:21 AM Evoke Pharma Q1 Net Loss $2.0 Mln Or $0.13/Shr Vs Loss $5.1 Mln Or $0.37/Shr Last Year
5/10/2018 7:35:49 AM Evoke Pharma Says Granted Gender Specific Patent For Gimoti In Mexico
3/26/2018 7:31:41 AM Evoke Announces Deal With Mallinckrodt To Amend Milestone Payments; Cash Runway Extended To January 2019
3/5/2018 7:37:38 AM Evoke Pharma: FDA Approves PDUFA Fee Waiver For Gimoti New Drug Application
11/9/2017 8:33:13 AM Evoke Pharma Signs Commercial Agreement With Thermo Fisher Scientific
10/23/2017 7:35:51 AM Evoke Pharma Announces Positive Topline Results From Comparative Exposure Pharmacokinetic Study For Gimoti
8/14/2017 8:34:10 AM Evoke Pharma Initiates Comparative Exposure Pharmacokinetic Study For Gimoti
3/21/2017 8:40:23 AM MYnd Analytics Receives A One Million Dollar Strategic Investment From The European-based RSJ Gradus Fund
3/21/2017 8:40:01 AM Evoke Pharma’s Phase 3 Results For Gimoti Accepted As Late-Breaker For Presentation
1/4/2017 8:37:52 AM Evoke Pharma Provides Additional Data From Phase 3 Trial Of Gimoti
7/20/2016 7:33:52 AM Evoke Pharma Announces $4.5 Mln At-The-Market Offering